Veraxa Biotech Holding AG (VRXA) Cash from Financing Activities (2025)
Veraxa Biotech Holding AG (VRXA) posted quarterly Cash from Financing Activities of $125117.0 for Q4 2025.
Veraxa Biotech Holding AG (VRXA) Cash from Financing Activities (2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Cash from Financing Activities for 1 consecutive years, with $125117.0 the latest figure, recorded in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 125,116.98 |
| Dec 31, 2025 | 125,116.98 |